Skip to content

Friday, December 1, 2023

Latest:

All about prosthesis
How neurotransmitters work together to detect odors
Turf vs. grass: field of dreams or field of injuries?
Baylor surgeon treats rare condition
Exploring the complexity of ethics and Artificial Intelligence: Reflections and responsibilities

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

pralsetinib

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

May 16, 2023May 16, 2023 endocrine therapy-resistant breast cancer, ER+ breast cancer, estrogen receptor 1, fusion genes, pralsetinib, Research, RET kinase

The findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.

From the Labs Image of the Month

From the Labs: Neural connections in the visual pathway of the brain

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951